Are Medical Stocks Lagging Doximity (DOCS) This Year?
Here is how Doximity (DOCS) and AxoGen (AXGN) have performed compared to their sector so far this year.
Dr Martens redemption arc will be ‘multi-year event'
The post-IPO narrative surrounding footwear icon Dr Martens PLC (LSE:DOCS) has been so overwhelmingly negative that it's easy to glance over the green shoots of optimism emerging from the business....
Dr Martens shares booted higher despite swinging to a loss
Dr Martens PLC (LSE:DOCS)'s double-digit revenue decline and pre-tax loss in the first half wasn't as bad as it seems, if the market's reaction is anything to go by. Shares in the shoe brand, which...
Dr Martens delivers double-digit sales decline and jumbo pre-tax loss
Dr Martens PLC (LSE:DOCS) had another unflattering trading performance in the first half of its financial year, with revenues declining 18% year-on-year to £325 million, in line with expectations. ...
Dr Martens set to unveil loss as all eyes on outlook in results
Dr Martens PLC (LSE:DOCS)'s first half results on Thursday, 28 November will likely be more about its outlook as a decline in sales and swing to loss are expected. According to Deutsche Bank analys...
Why Doximity Stock is Set to Open at Highest Point in Over 2 Years Friday
Doximity (DOCS) shares jumped nearly 40% in premarket trading Friday after the medical tech company's earnings and outlook came in above what analysts expected.
Doximity, Inc. (DOCS) Q2 2025 Earnings Call Transcript
Doximity, Inc. (NYSE:DOCS ) Q2 2025 Earnings Conference Call November 7, 2024 5:00 PM ET Company Participants Perry Gold - Vice President of Investor Relations Jeff Tangney - Co-Founder and CEO Ann...
Doximity (DOCS) Tops Q2 Earnings and Revenue Estimates
Doximity (DOCS) came out with quarterly earnings of $0.30 per share, beating the Zacks Consensus Estimate of $0.26 per share. This compares to earnings of $0.22 per share a year ago.
Doximity (DOCS) Outperforms Broader Market: What You Need to Know
Doximity (DOCS) closed at $41.88 in the latest trading session, marking a +1.11% move from the prior day.
Doximity (DOCS) Sees a More Significant Dip Than Broader Market: Some Facts to Know
In the most recent trading session, Doximity (DOCS) closed at $41.42, indicating a -1.76% shift from the previous trading day.
Overlooked Stock: DOCS
Doximity (DOCS) is trading near its 52-week high after getting an upgrade from Barclays. George Tsilis talks about why the "LinkedIn for physicians" can be gaining investor interest.
Doximity (DOCS) Increases Despite Market Slip: Here's What You Need to Know
Doximity (DOCS) reachead $40.88 at the closing of the latest trading day, reflecting a +0.62% change compared to its last close.
Should You Buy This Stock After It Skyrocketed by 33%?
Doximity recently reported strong financial results. The company has solid growth opportunities.
Doximity: Q1 Earnings Mark A Possible Turnaround For The Company (Rating Upgrade)
Doximity reported strong Q1 FY25 earnings with revenue and Adjusted EBITDA growing 17% and 41% YoY respectively, beating estimates. It saw a 16% increase in customer count in its $500K+ Subscriptio...
Doximity Stock Jumps 31%. Here's Why.
The medical platform's quarterly result beat expectations on both top and bottom lines, and is also leveraging AI to appeal to customers.
Related Companies